🇺🇸 ARWR — Arrowhead Pharmaceuticals, Inc.

Salud Compra fuerte
← Volver

Precio actual

61,65 USD

Máx. histórico

2.925,00

12011 días

Split 1:10 del 17/11/2011

Caída desde máximo

-97,89%

Rango 52 semanas

37,06 – 95,49

Variación hoy

+3,56%

Cierre anterior

59,53

Rango de hoy

59,06 – 61,99

Volumen hoy

1.487.357

Peor caída histórica

-99,96%

16/12/1993 → 16/12/2016

Aún sin recuperar

Volatilidad anualizada ⓘ

231,86%

Información
Nombre completo
Arrowhead Pharmaceuticals, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
711
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
107,71 USD (puede no estar actualizado)
Primera cotización
16/12/1993
Precio actualizado
hace 9 horas
Sobre la empresa

Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. Its pipeline includes Plozasiran to reduce production of apolipoprotein C-III in Phase 3 studies; Zodasiran to reduce production of angiopoietin-like protein 3 in Phase 3 clinical trials; ARO-DIMER-PA, a dual functional RNAi molecule in a Phase 1/2a clinical trials; and ARO-PNPLA3, an investigational RNAi therapeutic in Phase 1 clinical trials. The company also develops ARO-INHBE, to reduce the hepatic expression of the INHBE gene and its secreted gene product, Activin E in Phase 1/2a clinical trials; ARO-ALK7 to silence adipocyte expression of the ACVR1C gene in Phase 1/2a clinical trials; ARO-RAGE to reduce production of the receptor for advanced glycation end products in Phase 1/2a clinical trials; and ARO-MAPT, an investigational RNAi-based therapy. In addition, it is developing ARO-C3 to reduce production of C3 in Phase 1/2a clinical trials; and ARO-CFB to reduce hepatic expression of CFB in a Phase 1/2a clinical trials. The company has collaboration and license Agreements with Glaxosmithkline Intellectual Property (No. 3) Limited; Takeda Pharmaceutical Company Limited; Amgen Inc.; and Sarepta Therapeutics, Inc. Arrowhead Pharmaceuticals, Inc. was founded in 2003 and is headquartered in Pasadena, California.

Splits Registrados en el histórico de precios
Fecha Ratio
17/11/2011 1:10
15/01/2004 1:65
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
08/07/2020 44,63 45,31 44,25 45,25 +2,28% 2,38% 762.600
07/07/2020 43,69 45,72 43,15 44,24 +1,19% 5,87% 948.600
06/07/2020 44,54 45,16 43,49 43,72 -1,09% 3,75% 816.900
02/07/2020 44,62 45,20 43,00 44,20 +0,09% 4,93% 944.700
01/07/2020 43,20 44,80 42,94 44,16 +2,25% 4,31% 1.245.600
30/06/2020 42,61 43,41 41,34 43,19 +1,38% 4,86% 972.300
29/06/2020 43,28 43,54 42,03 42,60 -1,55% 3,49% 1.086.400
26/06/2020 42,00 43,84 41,34 43,27 +2,46% 5,95% 2.110.400
25/06/2020 39,39 42,39 38,31 42,23 +6,21% 10,36% 1.236.800
24/06/2020 41,48 42,21 39,03 39,76 -4,79% 7,67% 1.343.000
23/06/2020 40,08 42,97 39,83 41,76 +4,85% 7,83% 2.065.800
22/06/2020 36,49 40,02 35,64 39,83 +8,44% 12,00% 1.438.000
19/06/2020 36,91 37,14 35,54 36,73 +0,03% 4,33% 2.748.400
18/06/2020 35,48 37,62 35,24 36,72 +3,41% 6,71% 949.400
17/06/2020 35,86 36,24 34,65 35,51 -0,67% 4,43% 1.054.200
16/06/2020 34,20 36,17 33,62 35,75 +7,62% 7,45% 1.158.500
15/06/2020 31,81 33,58 31,11 33,22 +1,50% 7,76% 962.600
12/06/2020 32,72 32,79 30,83 32,73 +3,64% 5,99% 1.105.200
11/06/2020 34,09 34,19 31,29 31,58 -9,80% 8,51% 1.481.900
10/06/2020 35,06 35,79 33,93 35,01 -0,37% 5,31% 1.018.700
09/06/2020 35,22 35,91 34,90 35,14 -1,68% 2,87% 691.800
08/06/2020 34,53 35,74 34,00 35,74 +4,90% 5,04% 797.800
05/06/2020 32,93 34,54 31,85 34,07 +4,99% 8,17% 1.154.700
04/06/2020 31,64 32,97 31,50 32,45 +1,37% 4,65% 1.103.600
03/06/2020 33,10 33,25 31,96 32,01 -2,32% 3,91% 740.100
02/06/2020 33,43 33,52 31,61 32,77 -1,62% 5,71% 952.400
01/06/2020 32,10 33,65 31,91 33,31 +3,32% 5,42% 1.027.000
29/05/2020 33,29 33,42 31,56 32,24 -2,57% 5,59% 1.634.600
28/05/2020 33,97 34,62 32,65 33,09 -1,72% 5,80% 1.206.200
27/05/2020 33,71 34,23 31,57 33,67 -0,12% 7,89% 1.874.500